PET changes similar for Alzheimer’s disease, Down syndrome
Dec 20, 2022
“This study shows that, although there are subtle differences, Alzheimer’s disease pathophysiology is similar among people with Down syndrome and people with autosomal dominant Alzheimer’s...
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.
More news for Tuesday, Oct. 18
By
Kimberly Bonvissuto
Oct 18, 2022
Brookdale completes $220M refinancing of most 2023 debt maturities … Alzheimer’s Association names new CEO … Florida’s efforts to protect LTC residents from Hurricane Ian worked: AARP … South...
More news for Tuesday, July 11
By
Kimberly Bonvissuto
Jul 11, 2023
Average senior housing and care cap rates, rents expected to trend up in 2023 … HUD makes $30M available to fair housing enforcement partners … New Hampshire launches brain health public awareness...
Appendicular lean mass linked to decrease in Alzheimer’s risk
Jul 10, 2023
A higher appendicular lean mass also was associated with increased cognitive performance.
Intranasal insulin may have pro-cognitive benefits
Jun 30, 2023
Improvement in global cognition was seen for patients with Alzheimer’s disease/mild cognitive impairment, but no effects were seen for healthy individuals or other patient populations.
Resident falls account for 75 percent of insurance claims with payment in senior living
By
Kimberly Bonvissuto
Mar 06, 2023
Resident falls claims continue to be the primary insurance loss driver for senior living providers, according to a new report.
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.
55% expect no change in value of seniors housing this year
By
Lois A. Bowers
Mar 22, 2018
Almost 55% of respondents to a survey by professional services firm JLL said they believe that no change will occur in the value of seniors housing over the next year.
Strategies needed to improve delivery of Alzheimer’s disease-modifying therapies
Jan 30, 2024
Models that enable primary care practitioners to diagnose disease and evaluate patients for treatment eligibility would have biggest effect on wait times, the study found.